The Challenge Weeks

In 2022, Scott Moss created The Challenge Year and embarked on a year’s worth of monthly challenges to inspire, spark ideas and empower gratitude to become the best version of himself - and hopefully encourage others to do the same. However, the universe had another challenge waiting for him at the culmination of The Challenge Year when he was diagnosed with cancer while his wife was pregnant with their first child.

To honor our team leader Scott during this 10-week fundraiser, we are reimagining The Challenge Year into Challenge Weeks and we are inviting YOU to join us. Check out the details below on how you can join the challenge and fight back against cancer.

Here’s how you can join the challenge!

1 . Sign up below

The first step is to make your commitment by signing up below! Once you sign up, you will receive weekly emails for our Challenge Weeks.

2. Follow us

The next step is to follow us on your favorite social media platform. We’ll be posting a new set of challenges every Sunday starting March 9. Make sure to turn on notifications so you can stay engaged and not miss out on any information.

3 . Choose a challenge

Each Sunday, one of our honorees will offer three challenges that they think mirror Scott’s original mission. You will choose one of those three challenges and commit to it for the next five days (Monday through Friday).

4 . Share your journey

Announce your commitment to your socials and post your progress throughout the week. Don’t forget to tag us @teamwhatif2025 so we can share your progress!

5 . Reflect & repeat

Reflection is one of the most important aspects of the Challenge Weeks. On Saturday, take time to reflect on your journey and the lessons you learned. If you’re feeling inspired, check back on our socials on Sunday to join the next challenge.

6 . Consider donating

Our challenge weeks promote our 10-week fundraiser supporting the Leukemia and Lymphoma Society. Every drop counts, and we’re counting on amazing patrons like you to join the fight against cancer.